Report Description Table of Contents Methodology Segmentation Cranial Implants Market Size & Trends The global cranial implants market was valued at USD 1.43 billion in 2024 and is projected to expand at a CAGR of 6.5% from 2025 to 2030. Market growth is primarily driven by the rising prevalence of traumatic injuries and wounds and the increasing incidence of road accidents. Key Highlights North America accounted for the largest revenue share (36.7%) of the cranial implants industry in 2024. Within North America, the U.S. market held a dominant 79.4% share in 2024, underscoring its regional leadership. By product, the customized segment led the market with an 87.9% share in 2024. By material, the polymer segment dominated in 2024, with PEEK polymer being widely used for cranial implants. By end use, the neurosurgery centers segment is projected to record the fastest CAGR during the forecast period. The market expansion is strongly linked to the global rise in head injuries caused by accidents, falls, and assaults. Cranial implants—manufactured from titanium, polymers, and ceramics—play a critical role in neurosurgery by repairing cranial defects, restoring structural integrity, and protecting the brain. Market Drivers The increasing number of road accidents and the high prevalence of Traumatic Brain Injury (TBI) are major growth catalysts. According to a World Health Organization report (December 2023), approximately 1.19 million people died in road accidents. Data from BRAIN-AMN (November 2022) indicates that 69 million individuals globally are affected by TBI. These statistics highlight the growing clinical need for cranial implants. Market Concentration & Characteristics The cranial implants industry is in a medium growth stage, with an accelerating pace of expansion. While not experiencing explosive growth, the market demonstrates steady and sustainable progress. Key demand drivers include: Rising incidence of TBI from accidents and falls Increasing need for reconstructive surgeries following tumor resections A study published in the American Journal of Preventive Medicine (April 2025) reported that in 2021, the global incidence of TBI was 20.84 million, while the prevalence reached 37.93 million. These figures directly correlate with the demand for cranial implants. Adoption Barriers and Emerging Trends Historically, adoption was limited by: Complexity of surgical procedures Shortage of skilled neurosurgeons High implant costs However, growth is accelerating due to: 3D printing and CAD/CAM technologies, enabling customized, patient-specific implants Improved surgical outcomes, reduced complications, and higher patient satisfaction For example, in April 2025, restor3d (U.S.) raised USD 38 million to advance fully 3D-printed implant systems, reflecting increased investment in innovation. Market Structure The cranial implants market is moderately concentrated: Major players include B. Braun SE, Johnson & Johnson Services, Inc., Stryker, and Zimmer Biomet. Numerous smaller, specialized companies also operate, offering niche solutions. Barriers to entry include stringent regulatory requirements and high R&D investment, which limit new entrants. While large players dominate, smaller firms contribute specialized innovations. Innovation Landscape The market demonstrates high innovation intensity, particularly in advanced materials and personalized implant designs. Stryker offers customized PEEK implants, engineered to match individual cranial defects for optimal surgical fit and improved outcomes. Mergers & Acquisitions (M&A) M&A activity is moderate: Large-scale consolidations are infrequent. Strategic acquisitions are common, enabling portfolio and capability expansion. For instance, in September 2022, Brainlab acquired Dr. Langer Medical GmbH, a neuromonitoring solutions provider. This integration enhances Brainlab’s neurosurgery portfolio, supporting safer and more precise cranial procedures. Regional Expansion North America remains the largest regional market. Other regions are showing increasing activity. In January 2022, Kelyniam Global, Inc. entered into a licensing agreement with Fin-ceramica faenza spa to distribute its hydroxyapatite cranial implant (CustomizedBone Service) in the U.S., expanding product availability in established markets. Product Insights Customized Products: Accounted for 87.9% share in 2024. Growth is driven by the rising incidence of TBIs and the need for patient-specific solutions. Customized implants, designed using MRI and CT imaging, provide superior fit and accuracy. Key players: Stryker (CMF PEEK customized implants), 3D Systems (VSP solutions). In April 2024, 3D Systems, Inc. received FDA approval and 510(k) clearance for a 3D-printed customized cranial implant solution. Non-Customized Products: Expected to record the fastest CAGR during the forecast period. Include standardized, pre-shaped implants available in multiple sizes and materials. Widely used for trauma, surgical, or congenital cranial defects. Key players: Stryker, Johnson & Johnson Services, Inc., B. Braun SE, Zimmer Biomet. Material Insights Polymer Segment: Dominated the market in 2024. PEEK polymer is widely used due to biocompatibility, imaging compatibility (CT, MRI), and adaptability for radiation therapy. Key providers: Xilloc Medical Int B.V., Johnson & Johnson Services, Inc., Stryker. Ceramic Segment: Expected to register the fastest CAGR. Ultrasound compatibility makes ceramics suitable for brain tumor treatments. According to the University of Gothenburg (October 2020), bioceramic implants stimulate skull bone regeneration, supporting segment growth. End Use Insights The hospital segment dominated the cranial implants industry and accounted for a XX% share in 2024. The high number of cranial implant procedures carried out in hospitals due to the availability of skilled neurosurgeons accounts for the high segment share. Hospitals have neurology departments dedicated to providing neurological treatments. In addition, the hospitals are medically fully equipped with advanced technologies and professional teams to consult in complex situations. Most diagnostic tests, such as CT and MRI, are performed in hospitals, offering integrated healthcare under one roof, which boosts the segment growth. The neurosurgery centers segment is expected to register the fastest CAGR during the forecast period. The rising incidence of TBIs and the high adoption of cranial implants are factors expected to drive the segment. Neurosurgery centers offer personalized treatment, enhancing a patient’s experience. The centers are dedicated to offering neurological solutions to both children and adults, providing consolidated care under one roof, boosting the segment growth. Regional Insights The North America cranial implants market held the largest revenue share of 36.7% of the cranial implants industry in 2024. This dominance can be attributed to the region's well-developed healthcare infrastructure and the increasing need for advanced neurosurgical procedures. A significant factor fueling this market expansion is the rising incidence of TBIs. According to data published by Brain Injury Canada in June 2024, it was estimated that approximately 165,000 individuals in Canada suffer TBI annually. The substantial number of TBI cases directly contributes to the growing adoption of cranial implants as a crucial intervention in treatment and rehabilitation, thereby driving the market growth in North America. The sophisticated healthcare systems in the region ensure better access to these advanced medical devices and procedures for a larger patient population affected by cranial injuries. U.S. Cranial Implants Market Trends The U.S. cranial implants market held the largest revenue share of 79.4% in 2024, demonstrating its dominance within the regional landscape. The increasing incidence of TBI is significantly propelling market expansion. According to Brain Injury Association of America, the U.S. witnesses 2.9 million TBI-related emergency department visits annually. Cranial implants are essential for addressing skull fractures and defects resulting from these injuries, as well as for reconstructive procedures following neurosurgical treatments. Therefore, the high volume of TBI cases serves as a primary catalyst for the demand and expansion of the cranial implants market within the country, requiring sophisticated medical solutions and fostering a strong market environment. Europe Cranial Implants Market Trends Europe cranial implants market accounted for a significant share in 2024. According to the European Union (EU) data published in February 2024, more than one-fifth of the population is aged 65 years and above, accounting for 21.3% of the total population in the region. According to the National Library of Medicine report published in September 2022, nearly 7.7 million people are living with TBI-related disabilities. Such rising prevalence is encouraging companies to offer innovative cranial implant solutions, boosting the market growth in the region. Germany cranial implants market is expected to grow due to the increasing incidence of TBI, which is the primary market driver. At the same time, the rising geriatric population is the secondary market driver. According to Rehacare, an international trade fair for rehabilitation, in July 2021, older individuals are more susceptible to TBIs due to falls. Hence, various companies are involved in innovating advanced solutions in the cranial implants market. Some key players driving the market are evonos GmbH & Co. KG, 3di GmbH, and KLS Martin Group. Asia Pacific Cranial Implants Market Trends Asia Pacific cranial implants market is estimated to register the fastest CAGR of 7.9% over the forecast period. Increasing road accidents, causing TBIs, and rising prevalence of brain tumors are primary market drivers. Other factors driving the market include a growing geriatric population, which is more susceptible to falls. According to the Connectivity Traumatic Brain Injury Australia, up to 200,000 Australians suffer from TBIs each year. Such instances encourage companies to innovate and develop advanced solutions, driving the regional market. The Indian cranial implants market is experiencing growth propelled by the increasing incidence of road accidents and a high prevalence of TBIs. Data from the Indian Head Injury Foundation indicates that India records the highest number of head injuries globally, resulting in over 100,000 fatalities, and approximately 1 million individuals suffer serious head injuries annually. These circumstances are driving the adoption of cranial implants as a necessary medical intervention, thereby contributing to the expansion of the market in India. China cranial implants market accounted for the largest share in the Asia Pacific cranial implants industry in 2024. This growth is majorly driven by the increasing prevalence of TBI due to rising road accidents and other incidents, as well as a growing geriatric population, which is more susceptible to falls. Furthermore, the advancements in healthcare infrastructure across China and increasing healthcare expenditure contribute to the greater adoption of cranial implant procedures. Key Cranial Implants Company Insights Some companies in the cranial implants market include B. Braun SE; Johnson & Johnson Services, Inc.; Stryker; evonos GmbH & Co. KG; Kelyniam Global Inc.; and Acumed LLC. Key companies are involved in strategic initiatives such as new product launches, collaboration with institutions and other industries, and establishing partnerships. B. Braun SE is a Germany-based medical and pharmaceutical devices company that offers a comprehensive portfolio of over 5,000 healthcare products. The company provides solutions relevant to the cranial implants market within this extensive range, specifically within its neurosurgery division. Its offerings in neurosurgery include cranial fixation, CranioFix and Neuro Plating System. This positions B. Braun SE as a significant participant in the broader neurosurgical and cranial implant landscape. Johnson & Johnson Services, Inc. is a global healthcare company offering a wide range of products such as feminine hygiene, baby care, beauty, and over-the-counter products. In addition, the company also provides products for cranial implants such as MatrixNEURO system, MatrixNEURO Preformed Mesh, and cranial tube clamps. Key Cranial Implants Companies: The following are the leading companies in the cranial implants market. These companies collectively hold the largest market share and dictate industry trends. B. Braun SE Johnson & Johnson Services Inc. Stryker Zimmer Biomet Acumed LLC evonos GmbH & Co. KG Medartis AG Renishaw plc. Kelyniam Global Anatomics Pty Ltd Recent Developments In August 2024, Longeviti Neuro Solutions, a neurotechnology company headquartered in Maryland, was granted a U.S. patent for its innovative translucent prosthetic cranial implant designed for application in neurosurgical procedures. This implant allows real-time, noninvasive brain monitoring and direct communication between the brain and external devices, significantly improving surgical outcomes and reducing monitoring costs and time worldwide. In April 2024, Kelyniam Global, a medical device manufacturing business, and Fin-ceramica Faenza s.p.a. received 510(k) clearance from the FDA for the NEOS Surgery Cranial LOOP fixation system, which can be utilized with Finceramica’s CustomizedBone hydroxyapatite cranial implant. This system, made from a biocompatible polymer, allows fast and secure bone flap fixation after craniotomies, supports clear post-operative imaging, and is suitable for both adults and children as young as seven years old due to its low infection risk and bone-like properties. In October 2023, 3D Systems, Inc. produced patient-specific (customized) 3D-printed cranial implant using point-of-care technologies at University Hospital Basel. These 3D-printed implants enable precise, customized treatment and highlight the growing importance of additive manufacturing in the expanding cranial implants market, expected to exceed $2 billion by 2030. Cranial Implants Market Report Scope Report Attribute Details Market size value in 2025 USD 1.52 billion Revenue forecast in 2030 USD 2.09 billion Growth rate CAGR of 6.5% from 2025 to 2030 Base year for estimation 2024 Historical data 2018 - 2023 Forecast period 2025 - 2030 Report updated May 2025 Quantitative units Revenue in USD million and CAGR from 2025 to 2030 Report coverage Revenue forecast, company ranking, competitive landscape, growth factors, trends Segments covered Product, material, end use, region Regional scope North America; Europe; Asia Pacific; Latin America; Middle East & Africa Country scope U.S.; Canada; Mexico; UK; Germany; France; Italy; Spain; Denmark; Sweden; Norway; Japan; China; India; Australia; South Korea; Thailand; Brazil; Argentina; South Africa; Saudi Arabia; UAE; Kuwait Key companies profiled B. Braun SE, Johnson & Johnson Services, Inc., Stryker, Zimmer Biomet, Acumed LLC, evonos GmbH & Co. KG, Medartis AG, Renishaw plc., Kelyniam Global Inc., Anatomics Pty Ltd Customization scope Free report customization (equivalent up to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope. Pricing and purchase options Avail customized purchase options to meet your exact research needs. Global Cranial Implants Market Report Segmentation This report forecasts revenue growth at global, regional, and country levels as well as provides an analysis of the latest trends in each of the sub-segments from 2018 to 2030. For this study, Grand View Research has segmented the cranial implants market report on the basis of product, material, end use, and region: Product Outlook (Revenue, USD Million, 2018 - 2030) Customized Non-Customized Material Outlook (Revenue, USD Million, 2018 - 2030) Polymer Ceramic Metal End Use Outlook (Revenue, USD Million, 2018 - 2030) Hospital Neurosurgery Centers Regional Outlook (Revenue, USD Million, 2018 - 2030) North America U.S. Canada Mexico Europe UK Germany France Italy Spain Denmark Sweden Norway Asia Pacific Japan China India Australia South Korea Thailand Latin America Brazil Argentina Middle East & Africa South Africa Saudi Arabia UAE Kuwait . 1. Introduction 1.1. Study Objective 1.2. Market Definition 1.3. Study Scope 1.3.1. Markets Covered 1.3.2. Geographic Scope 1.3.3. Years Considered 1.3.4. Stakeholders 2. Research Methodology 2.1. Data Procurement 2.2. Paid Database 2.2.1. Secondary Data 2.2.1.1. Key Secondary sources 2.2.2. Primary Data 2.2.2.1 Primary sources 2.2.2.2. Key Material insights 2.2.2.3. Primary interviews with experts 2.2.2.4. Key primary respondent list 2.3. Market Size Estimation 2.4. Bottom-Up and Top-Down Approaches 2.4.1. Bottom-Up Approach 2.4.1.1. Approach for arriving at Market size by bottom-up analysis 2.4.2. Top-Down Approach 2.4.2.1. Approach for Capturing Market Size by Top-Down Analysis 2.5. Market Breakdown and Data Triangulation 2.6. Research Methodology 2.7. Risk Assessment 3. Executive Summary 3.1 Cranial Implants Market: Post-Covid-19 3.1.1 Actual Scenario 3.1.2 Pessimistic Scenario 3.1.3 Optimistic Scenario 3.1.4 Market Summary 4. Material Outlook 4.1 Market Snapshot 4.2 Cranial Implants Market 4.2.1 Market, 2020 – 2028 (USD Million) 4.3 Regional Business Analysis 4.3.1 Market, by region, 2021-2030 (USD Million) 4.4 By Product Business Analysis 4.4.1 Market, By Product, 2021-2030 (USD Million) 4.5 By Material Business Analysis 4.5.1 Market, By Material, 2021-2030 (USD Million) 4.6 End-User Business Analysis 4.6.1 Market, By End-User, 2021-2030 (USD Million) 4.7 Value Chain Analysis 4.8 Market Variable Analysis 4.8.1 Market Drivers Analysis 4.8.2 Market Restraints Analysis 4.9 Business Environment Analysis Tool 4.9.1 Market PEST analysis 4.9.2 Market Porter’s analysis 4.10 Penetration & Growth Prospect Mapping 5. Market Dynamics 5.1. Introduction 5.2. Market Dynamics 5.2.1. Drivers 5.2.2. Restraints 5.2.3. Opportunities 5.2.4. Challenges 5.3. Impact of Covid-19 On Market 5.4. Value Chain Analysis 5.5. Ecosystem 5.6. Patent Analysis 5.7. Trade Analysis 5.8. Tariff Analysis 5.9. Case Study Analysis 5.10. Porter’s Five Forces Analysis 5.10.1 Threat of New Entrants 5.10.2 Threat of Substitutes 5.10.3 Bargaining Power of Buyers 5.10.4 Bargaining Power of Suppliers 5.10.5 Degree of Competition 5.11. End-User Analysis 5.11.1. Trends in End-User (2014-2020) 5.11.2. Trends in End-User (2021-2028) 5.12. Pricing Analysis 5.12.1. Average Price Trend Analysis (By Region, By Countries) 6. Competitive & Vendor Landscape 6.1. Company Market Share Analysis 6.2. Manufacturers Manufacturing Sites, Area Served, Product 6.3. Market Competitive Situation and Trends 6.4. Manufacturers Mergers & Acquisitions, Expansion Plans 7. Market: By Product Segment Analysis 7.1. Introduction 7.2. Sales Volume & Revenue Analysis (2021-2030) 7.3. Customized 7.3.1. Customized, 2021-2030 (USD Million) 7.4. Non-Customized 7.4.1. Non-Customized Market, 2021-2030 (USD Million) 8. Market: By Material Segment Analysis 8.1. Introduction 8.2. Sales Volume & Revenue Analysis (2021-2030) 8.3. Polymer 8.3.1. Polymer Market, 2021-2030 (USD Million) 8.4. Ceramic 8.4.1. Ceramic Market, 2021-2030 (USD Million) 8.5. Metal 8.5.1. Metal Market, 2021-2030 (USD Million) 9. Market: By End-User Segment Analysis 9.1. Introduction 9.2. Sales Volume & Revenue Analysis (2021-2030) 9.3. Neurosurgical Centres 9.3.1. Neurosurgical Centres Market, 2021-2030 (USD Million) 9.4. Hospitals 9.4.1. Hospitals Market, 2021-2030 (USD Million) 10. Market: Regional Outlook 10.1 North America 10.1.1. North America Market, By Product, 2021-2030 (USD Million) 10.1.2. North America Market, By Material, 2021-2030 (USD Million) 10.1.3. North America Market, by End-User, 2021-2030 (USD Million) 10.1.4. North America Market, by Country, 2021-2030 (USD Million) 10.1.4.1. U.S. 10.1.4.1.1. U.S. Market, By Product, 2021-2030 (USD Million) 10.1.4.1.2. U.S. Market, By Material, 2021-2030 (USD Million) 10.1.4.1.3. U.S. Market, by End-User, 2021-2030 (USD Million) 10.1.4.2. Canada 10.1.4.2.1. Canada Market, By Product, 2021-2030 (USD Million) 10.1.4.2.2. Canada Market, By Material, 2021-2030 (USD Million) 10.1.4.2.3. Canada Market, by End-User, 2021-2030 (USD Million) 10.2. Europe 10.2.1. Europe Market, By Product, 2021-2030 (USD Million) 10.2.2. Europe Market, By Material, 2021-2030 (USD Million) 10.2.3. Europe Market, by End-User, 2021-2030 (USD Million) 10.2.4. Europe Market, by country, 2021-2030 (USD Million) 10.2.4.1 U.K. 10.2.4.1.1. U.K. Market, By Product, 2021-2030 (USD Million) 10.2.4.1.2. U.K. Market, By Material, 2021-2030 (USD Million) 10.2.4.1.3. U.K. Market, by End-User, 2021-2030 (USD Million) 10.2.4.2. Germany 10.2.4.2.1. Germany Market, By Product, 2021-2030 (USD Million) 10.2.4.2.2. Germany Market, By Material, 2021-2030 (USD Million) 10.2.4.2.3. Germany Market, by End-User, 2021-2030 (USD Million) 10.2.4.3. France 10.2.4.3.1. France Market, By Product, 2021-2030 (USD Million) 10.2.4.3.2. France Market, By Material, 2021-2030 (USD Million) 10.2.4.3.3. France Market, by End-User, 2021-2030 (USD Million) 10.2.4.4. Rest of Europe 10.2.4.4.1. Rest of Europe Market, By Product, 2021-2030 (USD Million) 10.2.4.4.2. Rest of Europe Market, By Material, 2021-2030 (USD Million) 10.2.4.4.3. Rest of Europe Market, by End-User, 2021-2030 (USD Million) 10.3. Asia Pacific 10.3.1. Asia Pacific Market, By Product, 2021-2030 (USD Million) 10.3.2. Asia Pacific Market, By Material, 2021-2030 (USD Million) 10.3.3. Asia Pacific Market, by End-User, 2021-2030 (USD Million) 10.3.4. Asia Pacific Market, by country, 2021-2030 (USD Million) 10.3.4.1. China 10.3.4.1.1. China Market, By Product, 2021-2030 (USD Million) 10.3.4.1.2. China Market, By Material, 2021-2030 (USD Million) 10.3.4.1.3. China Market, by End-User, 2021-2030 (USD Million) 10.3.4.2. India 10.3.4.2.1. India Market, By Product, 2021-2030 (USD Million) 10.3.4.2.2. India Market, By Material, 2021-2030 (USD Million) 10.3.4.2.3. India Market, by End-User, 2021-2030 (USD Million) 10.3.4.3. Japan 10.3.4.3.1. Japan Market, By Product, 2021-2030 (USD Million) 10.3.4.3.2. Japan Market, By Material, 2021-2030 (USD Million) 10.3.4.3.3. Japan Market, by End-User, 2021-2030 (USD Million) 10.3.4.4. South Korea 10.3.4.4.1. South Korea Market, By Product, 2021-2030 (USD Million) 10.3.4.4.2. South Korea Market, By Material, 2021-2030 (USD Million) 10.3.4.4.3. South Korea Market, by End-User, 2021-2030 (USD Million) 10.3.4.5. Rest of ASIA PACIFIC 10.3.4.5.1. Rest of ASIA PACIFIC Market, By Product, 2021-2030 (USD Million) 10.3.4.5.2. Rest of ASIA PACIFIC Market, By Material, 2021-2030 (USD Million) 10.3.4.5.3. Rest of ASIA PACIFIC Market, by End-User, 2021-2030 (USD Million) 10.4. Latin America 10.4.1. Latin America Market, By Product, 2021-2030 (USD Million) 10.4.2. Latin America Market, By Material, 2021-2030 (USD Million) 10.4.3. Latin America Market, by End-User, 2021-2030 (USD Million) 10.4.4. Latin America Market, by country, 2021-2030 (USD Million) 10.4.4.1. Brazil 10.4.4.1.1. Brazil Market, By Product, 2021-2030 (USD Million) 10.4.4.1.2. Brazil Market, By Material, 2021-2030 (USD Million) 10.4.4.1.3. Brazil Market, by End-User, 2021-2030 (USD Million) 10.4.4.2. Mexico 10.4.4.2.1. Mexico Market, By Product, 2021-2030 (USD Million) 10.4.4.2.2. Mexico Market, By Material, 2021-2030 (USD Million) 10.4.4.2.3. Mexico Market, by End-User, 2021-2030 (USD Million) 10.4.4.3. Rest of Latin America 10.4.4.3.1. Rest of the Latin America Market, By Product, 2021-2030 (USD Million) 10.4.4.3.2. Rest of the Latin America Market, By Material, 2021-2030 (USD Million) 10.4.4.3.3. Rest of the Latin America Market, by End-User, 2021-2030 (USD Million) 10.5. MEA 10.5.1. MEA Market, By Product, 2021-2030 (USD Million) 10.5.2. MEA Market, By Material, 2021-2030 (USD Million) 10.5.3. MEA Market, by End-User, 2021-2030 (USD Million) 10.5.4. MEA Market, by Region, 2021-2030 (USD Million) 11. Competitive Landscape 11.1 B. BRAUN MELSUNGEN AG 11.1.1. Company overview 11.1.2. Financial performance 11.1.3. ProductPortfolio Analysis 11.1.4. Business Strategy & Recent Development 11.2. DePuy Synthes (a Johnson & Johnson subsidiary) 11.2.1. Company overview 11.2.2. Financial performance 11.2.3. Product Portfolio Analysis 11.2.4. Business Strategy & Recent Development 11.3. KLS Martin Group 11.3.1. Company overview 11.3.2. Financial performance 11.3.3. Product Portfolio Analysis 11.3.4. Business Strategy & Recent Development 11.4. Stryker Corporation 11.4.1. Company overview 11.4.2. Financial performance 11.4.3. Product Portfolio Analysis 11.4.4. Business Strategy & Recent Development 11.5. ZIMMER BIOMET HOLDINGS INC 11.5.1. Company overview 11.5.2. Financial performance 11.5.3. Product Portfolio Analysis 11.5.4. Business Strategy & Recent Development 11.6. Acumed 11.6.1. Company overview 11.6.2. Financial performance 11.6.3. Product Portfolio Analysis 11.6.4. Business Strategy & Recent Development 11.7. SYNIMED 11.7.1. Company overview 11.7.2. Financial performance 11.7.3. Product Portfolio Analysis 11.7.4. Business Strategy & Recent Development 11.8. Evonos GmbH & Co. KG 11.8.1. Company overview 11.8.2. Financial performance 11.8.3. Product Portfolio Analysis 11.8.4. Business Strategy & Recent Development 11.9. Medartis Holding AG 11.9.1. Company overview 11.9.2. Financial performance 11.9.3. Product Portfolio Analysis 11.9.4. Business Strategy & Recent Development 11.10. Renishaw PLC 11.10.1. Company overview 11.10.2. Financial performance 11.10.3. Product Portfolio Analysis 11.10.4. Business Strategy & Recent Development 11.11. Kelyiniam Global, Inc 11.11.1. Company overview 11.11.2. Financial performance 11.11.3. Product Portfolio Analysis 11.11.4. Business Strategy & Recent Development 11.12. Xilloc Medical BV. 11.12.1. Company overview 11.12.2. Financial performance 11.12.3. Product Portfolio Analysis 11.12.4. Business Strategy & Recent Development 11.13. Anatomics Pty Ltd. 11.13.1. Company overview 11.13.2. Financial performance 11.13.3. Product Portfolio Analysis 11.13.4. Business Strategy & Recent Development 11.14. BioArchitects 11.14.1. Company overview 11.14.2. Financial performance 11.14.3. Product Portfolio Analysis 11.14.4. Business Strategy & Recent Development 11.15. Bioplate Inc 11.15.1. Company overview 11.15.2. Financial performance 11.15.3. Product Portfolio Analysis 11.15.4. Business Strategy & Recent Development 11.16. EUROS SAS 11.16.1. Company overview 11.16.2. Financial performance 11.16.3. Product Portfolio Analysis 11.16.4. Business Strategy & Recent Development List of Tables (59 Tables) TABLE 1. Market, By Product, 2021-2030 (USD Million) TABLE 2. Market FOR Customized, BY REGION, 2021-2030 (USD Million) TABLE 3. Market FOR Non-Customized, BY REGION, 2021-2030 (USD Million) TABLE 4. Market, By Material, 2021-2030 (USD Million) TABLE 5. Market FOR Polymer, BY REGION, 2021-2030 (USD Million) TABLE 6. Market FOR Ceramic, BY REGION, 2021-2030 (USD Million) TABLE 7. Market FOR Metal, BY REGION, 2021-2030 (USD Million) TABLE 8. Market, BY END-USER, 2021-2030 (USD Million) TABLE 9. Market FOR Neurosurgical Centres, BY REGION, 2021-2030 (USD Million) TABLE 10. Market FOR Hospitals, BY REGION, 2021-2030 (USD Million) TABLE 11. Market, BY REGION, 2021-2030 (USD Million) TABLE 12. NORTH AMERICA Market, BY COUNTRY, 2021-2030 (USD Million) TABLE 13. NORTH AMERICA Market, By Product, 2021-2030 (USD Million) TABLE 14. NORTH AMERICA Market, By Material, 2021-2030 (USD Million) TABLE 15. NORTH AMERICA Market, BY END-USER, 2021-2030 (USD Million) TABLE 16. EUROPE Market, BY COUNTRY, 2021-2030 (USD Million) TABLE 17. EUROPE Market, By Product, 2021-2030 (USD Million) TABLE 18. EUROPE Market, By Material, 2021-2030 (USD Million) TABLE 19. EUROPE Market, BY END-USER, 2021-2030 (USD Million) TABLE 20. ASIA-PACIFIC Market, BY COUNTRY, 2021-2030 (USD Million) TABLE 21. ASIA-PACIFIC Market, By Product, 2021-2030 (USD Million) TABLE 22. ASIA-PACIFIC Market, By Material, 2021-2030 (USD Million) TABLE 23. ASIA-PACIFIC Market, BY END-USER, 2021-2030 (USD Million) TABLE 24. LAMEA Market, BY COUNTRY, 2021-2030 (USD Million) TABLE 25. LAMEA Market, By Product, 2021-2030 (USD Million) TABLE 26. LAMEA Market, By Material, 2021-2030 (USD Million) TABLE 27. LAMEA Market, BY END-USER, 2021-2030 (USD Million) TABLE 28. B. BRAUN MELSUNGEN AG.: COMPANY SNAPSHOT TABLE 29. B. BRAUN MELSUNGEN AG.: OPERATING SEGMENTS TABLE 30. DePuy Synthes (a Johnson & Johnson subsidiary): COMPANY SNAPSHOT TABLE 31. DePuy Synthes (a Johnson & Johnson subsidiary): OPERATING SEGMENTS TABLE 32. KLS Martin Group: COMPANY SNAPSHOT TABLE 33. KLS Martin Group: OPERATING SEGMENTS TABLE 34. Stryker Corporation: COMPANY SNAPSHOT TABLE 35. Stryker Corporation: OPERATING SEGMENTS TABLE 36. ZIMMER BIOMET HOLDINGS INC: COMPANY SNAPSHOT TABLE 37. ZIMMER BIOMET HOLDINGS INC: OPERATING SEGMENTS TABLE 38. Acumed: COMPANY SNAPSHOT TABLE 39. Acumed: OPERATING SEGMENTS TABLE 40. SYNIMED: COMPANY SNAPSHOT TABLE 41. SYNIMED: OPERATING SEGMENTS TABLE 42. Medartis Holding AG: COMPANY SNAPSHOT TABLE 43. Medartis Holding AG: OPERATING SEGMENTS TABLE 44. Renishaw PLC.: COMPANY SNAPSHOT TABLE 45. Renishaw PLC.: OPERATING SEGMENTS TABLE 46. Kelyiniam Global, Inc: COMPANY SNAPSHOT TABLE 47. Kelyiniam Global, Inc: OPERATING SEGMENTS TABLE 48. Evonos GmbH & Co. KG: COMPANY SNAPSHOT TABLE 49. Evonos GmbH & Co. KG: OPERATING SEGMENTS TABLE 50. Xilloc Medical BV.: COMPANY SNAPSHOT TABLE 51. Xilloc Medical BV.: OPERATING SEGMENTS TABLE 52. Anatomics Pty Ltd.: COMPANY SNAPSHOT TABLE 53. Anatomics Pty Ltd.: OPERATING SEGMENTS TABLE 54. BioArchitects: COMPANY SNAPSHOT TABLE 55. BioArchitects: OPERATING SEGMENTS TABLE 56. Bioplate Inc: COMPANY SNAPSHOT TABLE 57. Bioplate Inc: OPERATING SEGMENTS TABLE 58. EUROS SAS: COMPANY SNAPSHOT TABLE 59. EUROS SAS: OPERATING SEGMENTS List of Figures (21 Figures) Figure 1 Cranial Implants Market: Research Methodology Steps Figure 2 Research Design Figure 3 Breakdown of Primaries: Market Figure 4 Research Methodology: Hypothesis Building Figure 5 Market Product-Based Estimation Figure 6 Top 16 Companies with Highest No. Of Patent in Last 9 Years Figure 7 No. Of Patents Granted Per Year, 2019–2020 Figure 8 Import Data for Cranial Implants, By Country, 2016–2020 (USD Thousand) Figure 9 Export Data for Cranial Implants, By Country, 2016–2020 (USD Thousand) Figure 10 Data Triangulation Methodology Figure 11 Market, By Material, 2019 vs 2025 (USD Million) Figure 12 Market Share, By End-User, 2019 vs 2025 (USD Million) Figure 13 Market Share, By Product, 2019 vs 2025 (USD Million) Figure 14 Geographical Snapshot of the Market Figure 15 Neurosurgical Centres to Witness Higher CAGR in Market for End-User Segment during Forecast Period. Figure 16 Customized cranial implants to Witness Higher CAGR in Market for Product Segment during Forecast Period. Figure 17 Polymer-material to Witness Higher CAGR in the Market for Material Segment during Forecast Period. Figure 18 North America Region Accounted for the Largest Share of the Market, By Regional Basis, in 2019 Figure 19 Market: Drivers, Restraints, Opportunities, and Challenges Figure 20 North America: Market Snapshot Figure 21 Asia Pacific: Market Snapshot Figure 22 Vendor Dive: Evaluation Overview . .